SecBot SecBot
SECBOTREPLAY Home › Report › TEVA

TEVA · A federal magistrate judge in Kansas granted in part and denied in part…

TEVA PHARMACEUTICAL INDUSTRIES LTD · COURT-RULING filed Aug 24, 2026 at 20:00 ET

At the news

NEUTRALIMPACT 2/10

COURT-RULING filed Aug 24, 2026 at 20:00 ET

A federal magistrate judge in Kansas granted in part and denied in part a motion to compel non-party law firm Goodwin Procter to re-run document searches in the long-running EpiPen antitrust MDL against Teva. The court denied plaintiffs' request for additional search terms as untimely and insufficiently justified, but ordered Goodwin to submit two redacted email strings for in camera review. This is a routine discovery dispute with no material financial exposure or business impact on Teva, the ruling does not address liability, damages, or any substantive claim in the underlying antitrust case.

  • Ruling is a discovery dispute over non-party law firm Goodwin Procter's document production in the EpiPen antitrust MDL (Case 2:22-cv-02501-DDC-TJJ).
  • Court denied plaintiffs' request to compel Goodwin to run additional search terms, finding the motion untimely and the burden outweighed the likely benefit.
  • Court granted in part plaintiffs' request regarding two redacted email strings, ordering Goodwin to submit unredacted versions for in camera review.
  • No damages, injunction, or liability finding was made against Teva, the ruling concerns only procedural discovery obligations of a non-party law firm.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access